AXA Framlington Health Fund Z Acc
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
413.30p
0.60p (+0.15%)
Fund Code
FMHEA
B6WZJX0
GB00B6WZJX05
Prices updated as at 28 Mar 2025
|
Prices in GBX
Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Portfolio as of 31/01/2025
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Large growth
26.96%
% Weight
Value
Core
Growth
Large
24
18
27
Medium
0
12
10
Small
2
2
5
Valuation
AXA Framlington Health Fund Z Acc
Sector Equity Healthcare
19.67
1.90
4.14
17.67
Growth rate
AXA Framlington Health Fund Z Acc
Sector Equity Healthcare
11.50%
1.25%
-0.08%
Top 10 holdings
Security name | Sector | Country | % of assets | |
---|---|---|---|---|
1 | Eli Lilly and Co | - | United States | 8.67 |
2 | Merck & Co Inc | - | United States | 4.98 |
3 | Thermo Fisher Scientific Inc | - | United States | 4.98 |
4 | UnitedHealth Group Inc | - | United States | 4.87 |
5 | Novo Nordisk AS Class B | - | Denmark | 4.83 |
6 | AstraZeneca PLC | - | United Kingdom | 4.53 |
7 | Becton Dickinson & Co | - | United States | 4.37 |
8 | Intuitive Surgical Inc | - | United States | 3.70 |
9 | DexCom Inc | - | United States | 3.43 |
10 | Boston Scientific Corp | - | United States | 2.79 |
Assets in top 10 holdings %
47.15%
Total no. of equity holdings
47.00
Total no. of bond holdings
-
Stock sectors
AXA Framlington Health Fund Z Acc
Sector Equity Healthcare
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
1.20%
Comm services
Energy
Industrials
Technology
98.80%
Con defensive
Healthcare
Utilities